De Novo Variants in the Splicing Factor Gene SF3B1 Are Associated with Neurodevelopmental Disorders - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

De Novo Variants in the Splicing Factor Gene SF3B1 Are Associated with Neurodevelopmental Disorders

Constitutional variants in the splicing factor SF3B1 have been linked to neurodevelopmental disorders for the first time, according to a new multinational study co-authored by Phoenix Children’s Pediatric Neurologist and Neurogeneticist Michael Kruer, MD, et al. 

  • By

  • August 14, 2026

  • 2 min

Share

Original Source(s)

De Novo Variants in the Splicing Factor Gene SF3B1 Are Associated with Neurodevelopmental Disorders

  • by

  • August 14, 2026

Related Content

Errors in Methods and Supplement 1

  • August 1, 2026

Impact of cognitive impairment on postoperative delirium and discharge disposition following knee arthroplasty: a Japanese nationwide propensity score–matched study

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.